7e490df9adf774a12a223cb2def04c150a3a9bc8
morinlab.bib
| ... | ... | @@ -1,3 +1,23 @@ |
| 1 | +@article{veazeyCARM1InhibitionReduces2020b, |
|
| 2 | + title = {{{CARM1}} Inhibition Reduces Histone Acetyltransferase Activity Causing Synthetic Lethality in {{CREBBP}}/{{EP300-mutated}} Lymphomas}, |
|
| 3 | + author = {Veazey, Kylee J. and Cheng, Donghang and Lin, Kevin and Villarreal, Oscar D. and Gao, Guozhen and Perez-Oquendo, Mabel and Van, Hieu T. a$ |
|
| 4 | + date = {2020-12}, |
|
| 5 | + journaltitle = {Leukemia}, |
|
| 6 | + shortjournal = {Leukemia}, |
|
| 7 | + volume = {34}, |
|
| 8 | + number = {12}, |
|
| 9 | + eprint = {32576962}, |
|
| 10 | + eprinttype = {pmid}, |
|
| 11 | + pages = {3269--3285}, |
|
| 12 | + issn = {1476-5551}, |
|
| 13 | + doi = {10.1038/s41375-020-0908-8}, |
|
| 14 | + abstract = {Somatic mutations affecting CREBBP and EP300 are a hallmark of diffuse large B-cell lymphoma (DLBCL). These mutations are frequently mo$ |
|
| 15 | + langid = {english}, |
|
| 16 | + pmcid = {PMC7688486}, |
|
| 17 | + keywords = {Acetylation,Animals,Cell Line,CREB-Binding Protein,Down-Regulation,E1A-Associated p300 Protein,Histone Acetyltransferases,Lymphoma Larg$ |
|
| 18 | + file = {/Users/rmorin/Zotero/storage/NHIN6APN/Veazey et al. - 2020 - CARM1 inhibition reduces histone acetyltransferase.pdf} |
|
| 19 | +} |
|
| 20 | + |
|
| 1 | 21 | @article{scholzeCombinedEZH2Bcl22020b, |
| 2 | 22 | title = {Combined {{EZH2}} and {{Bcl-2}} Inhibitors as Precision Therapy for Genetically Defined {{DLBCL}} Subtypes.}, |
| 3 | 23 | author = {Scholze, Hanna and Stephenson, Regan E. and Reynolds, Raymond and Shah, Shivem B. and Puri, R. and Butler, Scott D. and Trujillo-Alonso, Vicenta and Teater, Matt and family=Besien, given=Herman, prefix=van, useprefix=false and Gibbs-Curtis, Destini and Ueno, H. and Parvin, S. and Letai, A. and Mathew, S. and Singh, Ankur and Cesarman, E. and Melnick, A. and Giulino‐Roth, L.}, |